Fulminant B viral hepatitis: role of delta agent.

Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-binding activity. J Virol (1988) 3.11

Characterization of hepatitis delta antigen: specific binding to hepatitis delta virus RNA. J Virol (1990) 2.17

Characterization of nuclear targeting signal of hepatitis delta antigen: nuclear transport as a protein complex. J Virol (1992) 1.63

RNA replication without RNA-dependent RNA polymerase: surprises from hepatitis delta virus. J Virol (2005) 1.21

Isoprenylation mediates direct protein-protein interactions between hepatitis large delta antigen and hepatitis B virus surface antigen. J Virol (1993) 1.15

Random mutations to evaluate the role of bases at two important single-stranded regions of genomic HDV ribozyme. Nucleic Acids Res (1992) 1.14

Nuclear localization signals, but not putative leucine zipper motifs, are essential for nuclear transport of hepatitis delta antigen. J Virol (1992) 1.07

Deletion of internal sequence on the HDV-ribozyme: elucidation of functionally important single-stranded loop regions. Nucleic Acids Res (1992) 1.04

Hepatitis delta virus ribonucleoproteins shuttle between the nucleus and the cytoplasm. RNA (2002) 1.02

Delta hepatitis: molecular biology and clinical and epidemiological features. Clin Microbiol Rev (1993) 0.94

Prevalence of hepatitis delta (delta) virus infection. A seroepidemiologic study. West J Med (1988) 0.94

Modification of small hepatitis delta virus antigen by SUMO protein. J Virol (2009) 0.92

Relapse of acute B viral hepatitis--role of delta agent. Gut (1986) 0.91

Hepatitis D virus genotypes in intravenous drug users in taiwan: decreasing prevalence and lack of correlation with hepatitis B virus genotypes. J Clin Microbiol (2002) 0.90

Hepatitis B surface antigen levels and sequences of natural hepatitis B virus variants influence the assembly and secretion of hepatitis d virus. J Virol (2007) 0.87

Hepatitis delta virus RNA replication. Viruses (2009) 0.84

Interaction and replication activation of genotype I and II hepatitis delta antigens. J Virol (2004) 0.83

Hepatitis delta virus: a peculiar virus. Adv Virol (2013) 0.82

Acute delta hepatitis without circulating HBsAg. Gut (1985) 0.81

Positive selection of hepatitis delta antigen in chronic hepatitis D patients. J Virol (2007) 0.79

A retrospective autopsy study of histopathologic spectrum and etiologic trend of fulminant hepatic failure from north India. Diagn Pathol (2007) 0.78

"Defective" mutations of hepatitis D viruses in chronic hepatitis D patients. World J Gastroenterol (2005) 0.77

Hepatitis D virus isolates with low replication and epithelial-mesenchymal transition-inducing activity are associated with disease remission. J Virol (2012) 0.77

In Vivo Interaction of the Hepatitis Delta Virus Small Antigen with the ELAV-Like Protein HuR. Open Virol J (2011) 0.76

Viral superinfection in previously unrecognized chronic carriers of hepatitis B virus with superimposed acute fulminant versus nonfulminant hepatitis. J Clin Microbiol (1999) 0.76

Therapy of Delta Hepatitis. Cold Spring Harb Perspect Med (2015) 0.76

Delta hepatitis: identification, epidemiologic features and prevention. CMAJ (1986) 0.75

Clinicopathological study of fulminant hepatitis: coinfection with hepatitis B virus and delta agent. CMAJ (1986) 0.75

Fulminant hepatic failure. West J Med (1988) 0.75

Searching for nuclear export elements in hepatitis D virus RNA. World J Virol (2013) 0.75

Delta hepatitis in Denver. West J Med (1988) 0.75

Chronic hepatitis: a review. J R Soc Med (1985) 0.75

Hepatitis D Virus Infection Among Hepatitis B Surface Antigen Carriers and in "Isolated anti-HBc" Antibodies Profile in Central Tunisia. Hepat Mon (2016) 0.75

Recent advances in managing hepatitis D. F1000Res (2017) 0.75

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science (1989) 18.79

Lack of protective immunity against reinfection with hepatitis C virus. Science (1992) 4.94

Molecular cloning and sequencing of a human hepatitis delta (delta) virus RNA. Nature (1987) 4.52

Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer (1980) 3.82

Genetic and experimental evidence for cross-species infection by swine hepatitis E virus. J Virol (1998) 3.73

Group-specific antigen expression during embryogenesis of the genome of the C-type RNA tumor virus: implications for ontogenesis and oncogenesis. Proc Natl Acad Sci U S A (1970) 3.71

The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men. Ann Intern Med (1982) 3.69

Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci U S A (1994) 3.56

HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J Immunol (1993) 3.42

Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-binding activity. J Virol (1988) 3.11

A single antigenomic open reading frame of the hepatitis delta virus encodes the epitope(s) of both hepatitis delta antigen polypeptides p24 delta and p27 delta. J Virol (1988) 2.99

Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees. Proc Natl Acad Sci U S A (2000) 2.70

Heme biosynthesis in intermittent acute prophyria: decreased hepatic conversion of porphobilinogen to porphyrins and increased delta aminolevulinic acid synthetase activity. Proc Natl Acad Sci U S A (1970) 2.33

Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst (1990) 2.23

Characterization of hepatitis delta antigen: specific binding to hepatitis delta virus RNA. J Virol (1990) 2.17

Extra- and intrahepatic portal hypertension without cirrhosis (hepatoportal sclerosis). Ann Surg (1965) 2.10

Synthesis of a novel hepatitis C virus protein by ribosomal frameshift. EMBO J (2001) 2.03

Liver transplantation for advanced liver disease with alpha-1-antitrypsin deficiency. N Engl J Med (1980) 2.00

Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin. N Engl J Med (1971) 1.98

The reciprocal relation between caloric intake and the degree of hyperbilirubinemia in Gilbert's syndrome. N Engl J Med (1970) 1.96

Mutliple hepatitis viruses in multiple attacks of acute viral hepatitis. N Engl J Med (1977) 1.95

Primary biliary cirrhosis with scleroderma, Raynaud's phenomenon and telangiectasia. New syndrome. Am J Med (1971) 1.90

Comparison of serum hepatitis B surface antigen (HBsAg) and serum anticore with tissue HBsAg and hepatitis B core antigen (HBcAg). Gastroenterology (1978) 1.89

Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan. Ann Intern Med (1971) 1.89

Epidemiology of hepatocellular carcinoma. Can J Gastroenterol (2000) 1.80

Liver allograft. Its use in chronic active hepatitis with macronodular cirrhosis, hepatitis B surface antigen. Arch Surg (1979) 1.80

Decreased red cell uroporphyrinogen I synthetase activity in intermittent acute porphyria. J Clin Invest (1972) 1.80

Pathogenesis and treatment of hydrothorax complicating cirrhosis with ascites. Ann Intern Med (1966) 1.79

Prevalence of the group-specific (gs) antigen and infectious virus expressions of the murine C-type RNA viruses during the life span of BALB-cCr mice. Int J Cancer (1972) 1.70

Subdeterminants d and y of hepatitis B antigen as epidemiologic markers. Am J Epidemiol (1972) 1.70

Prevalence of delta-antibody among chronic hepatitis B virus infected patients in the Los Angeles area: its correlation with liver biopsy diagnosis. Gastroenterology (1983) 1.70

Etiology of sporadic hepatitis B surface antigen-negative hepatitis. Ann Intern Med (1977) 1.63

The adaptive evolution database (TAED). Genome Biol (2001) 1.62

Lymphocyte stimulation in hepatitis B infections. N Engl J Med (1975) 1.60

NK cells cause liver injury and facilitate the induction of T cell-mediated immunity to a viral liver infection. J Immunol (2000) 1.60

Gross anatomic features of hepatocellular carcinoma from three disparate geographic areas. Proposal of new classification. Cancer (1984) 1.57

Recombinant hepatitis E virus genomes infectious for primates: importance of capping and discovery of a cis-reactive element. Proc Natl Acad Sci U S A (2001) 1.54

Liver replacement for alpha1-antitrypsin deficiency. Surgery (1977) 1.53

Variation in course of hepatitis E in experimentally infected cynomolgus monkeys. J Infect Dis (1993) 1.52

Percutaneous transhepatic cholangiography. An improved technique. JAMA (1975) 1.51

Long term follow-up studies of patients surviving fluminant viral hepatitis. Gastroenterology (1974) 1.51

Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. J Natl Cancer Inst (1991) 1.50

Hepatitis B immune globulin as a prophylactic measure for spouses exposed to acute type B hepatitis. N Engl J Med (1975) 1.50

Controlled trial of exchange-transfusion therapy in fulminant hepatitis. Lancet (1973) 1.50

Twenty isoniazid-associated deaths in one state. Am Rev Respir Dis (1989) 1.50

Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV. Hepatology (2000) 1.49

Murine C-type RNA virus from spontaneous neoplasms: in vitro host range and oncogenic potential. Science (1973) 1.48

Viral hepatitis: clinical aspects. Am J Med Sci (1976) 1.45

Hepatitis B virus infection in dentists. N Engl J Med (1975) 1.44

Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol (1997) 1.39

Experimental infection of chimpanzees with hepatitis C virus of genotype 5a: genetic analysis of the virus and generation of a standardized challenge pool. J Infect Dis (1998) 1.38

Naturally occurring sarcoma virus of the BALB/cCr mouse. J Natl Cancer Inst (1974) 1.38

Hepatitis C antibodies in patients with alcoholic liver disease commonly have an identifiable risk factor. J Clin Gastroenterol (1992) 1.38

Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc Natl Acad Sci U S A (1994) 1.38

Primary hepatocellular carcinoma following perinatal transmission of hepatitis B. West J Med (1988) 1.38

Direct transhepatic measurement of portal vein pressure using a thin needle. Comparison with wedged hepatic vein pressure. Gastroenterology (1977) 1.38

Host range studies of GB virus-B hepatitis agent, the closest relative of hepatitis C virus, in New World monkeys and chimpanzees. J Med Virol (2001) 1.37

Experimental transmission of hepatitis C virus-associated fulminant hepatitis to a chimpanzee. J Infect Dis (1999) 1.35

Familial hepatoma with hepatitis-associated antigen. Ann Intern Med (1971) 1.34

cDNA clone of hepatitis A virus encoding a virulent virus: induction of viral hepatitis by direct nucleic acid transfection of marmosets. J Virol (1992) 1.33

Hepatocellular carcinoma and oral contraceptives. Br J Cancer (1983) 1.30

Ebola (subtype Reston) virus among quarantined nonhuman primates recently imported from the Philippines to the United States. J Infect Dis (1999) 1.29

Chronic liver disease after acute non-A, non-B viral hepatitis. Gastroenterology (1979) 1.28

Porphyria cutanea tarda. A study of the effect of phlebotomy. N Engl J Med (1968) 1.28

Hepatic necrosis associated with halothane anesthesia. Am J Med (1969) 1.27

A cohort study of serum testosterone and hepatocellular carcinoma in Shanghai, China. Int J Cancer (1995) 1.26

Hepatitis C virus-associated fulminant hepatic failure. N Engl J Med (1996) 1.23

Heterogeneity of hepatitis delta antigen. Virology (1990) 1.23

Piperazinediium dioxamate. Acta Crystallogr Sect E Struct Rep Online (2009) 1.21

Cirrhosis associated with partial deficiency of alpha-1 antitrypsin in an adult. Ann Intern Med (1973) 1.21

Viral hepatitis b in neonates and infants. Am J Med (1973) 1.20

Hepatits A virus infection in fulminant hepatitis and chronic active hepatitis. Gastroenterology (1978) 1.19

Improved detection of hepatitis C virus antibodies in high-risk populations. Hepatology (1992) 1.18

Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus. J Infect Dis (2000) 1.18

Hepatitis B surface antigen in pancreatic and biliary secretions. Gastroenterology (1980) 1.17

Molecular cloning and characterization of an isolate of hepatitis delta virus from Taiwan. Hepatology (1991) 1.17

Patients co-infected with human immunodeficiency virus and hepatitis C virus demonstrate higher levels of hepatic HCV RNA. J Viral Hepat (1999) 1.16

Results of a 12-year randomized trial of portacaval shunt in patients with alcoholic liver disease and bleeding varices. Gastroenterology (1981) 1.15

A comparative study of hepatitis B viral markers in the family members of Asian and non-Asian patients with hepatitis B surface antigen-positive hepatocellular carcinoma and with chronic hepatitis B infection. J Infect Dis (1979) 1.15

Advances in directed protein evolution by recursive genetic recombination: applications to therapeutic proteins. Curr Opin Biotechnol (2001) 1.14

A double-blinded, randomized trial of hydrocortisone in acute hepatic failure. The Acute Hepatic Failure Study Group. Dig Dis Sci (1991) 1.13

Functional inferences from reconstructed evolutionary biology involving rectified databases--an evolutionarily grounded approach to functional genomics. Res Microbiol (2000) 1.13

Evolution of hepatitis delta virus RNA during chronic infection. Virology (1992) 1.13

Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis. Am J Gastroenterol (1999) 1.13

5-Flourouracil in hepatocellular carcinoma: report of twenty-one cases. Cancer (1977) 1.13

Functional renal failure with cirrhosis. The effect of plasma expansion therapy. Medicine (Baltimore) (1967) 1.12

Porphyria cutanea tarda symptomatica (PCT-S). A study of the effect of phlebotomy therapy. Arch Dermatol (1965) 1.11

Smoking as an independent risk factor for hepatocellular carcinoma: the Singapore Chinese Health Study. Br J Cancer (2011) 1.10

Fulminant hepatitis A in intravenous drug users with chronic liver disease. Ann Intern Med (1989) 1.09

Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C. Gastroenterology (1994) 1.09

Letter: Randomization of corticosteroid therapy in fulminant hepatitis. N Engl J Med (1976) 1.08